Terns Pharmaceuticals, Inc. · NASDAQ:TERN

Deep Track Capital, LP reported a 6.39% stake in Terns Pharmaceuticals, Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 15, 2025

Deep Track Capital, LP reported a 6.39% stake in Terns Pharmaceuticals, Inc., 5,576,558 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).

Stake
6.39%
Shares
5,576,558
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Deep Track Capital, LP6.39%5,576,558
Deep Track Biotechnology Master Fund, Ltd.6.39%5,576,558
David Kroin6.39%5,576,558

Source

View original at SEC

Related